Scientists have demonstrated a new strategy for treating autoimmune disease that successfully blocked the development of rheumatoid arthritis in a mouse model. They say it holds promise for improved ...
First Anti-TNF Infusion Therapy Approved in More Than a Decade for Patients Living with Moderately to Severely Active Rheumatoid Arthritis "Phase 3 data showed treatment with SIMPONI ARIA plus ...
SIMPONI ARIA (golimumab) 50mg/4mL single-use vial Simponi Aria (golimumab for infusion; Janssen Biotech) has received approval from the FDA for the treatment of adults with moderately to severely ...
Rituxan (rituximab) is a prescription drug used to treat certain cancers, rheumatoid arthritis (RA), and other conditions. Rituxan comes as an intravenous (IV) infusion. Rituxan is a type of ...
Truxima is a biosimilar version of the brand-name drug Rituxan. Biosimilars tend to be less expensive than their brand-name versions. Doctors prescribe Truxima to treat conditions such as rheumatoid ...
The prospect of long-lasting drug-free remission for children and adults living with inflammatory arthritis is a step closer ...
A United States of America – trained physician Dr. Helen Mbakwe, has unveiled the country’s first outpatient infusion and arthritis management center in Abuja. Mbakwe said that the newly launched ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback